Global Consortium Inc. (GCGX) Establishes New Nutraceuticals Line, Explores Taking One Division Public in Canada
GCGX is a diversified cannabis holding company with $100 million in projected revenue for 2019 The company’s nutraceuticals division is to be overseen by medical physicians and veterinarians focused on diverse specialties GCGX’s product line is developed with proprietary infused formulas to include lotions, balms, ointments, liquids, pills and powders Discussions are underway to take one of the company’s divisions public in Canada in order to raise capital and open up growth potential From its headquarters in Florida, Global Consortium Inc. (OTC: GCGX), a diversified cannabis holding company expanding its reach nationwide with several subsidiaries, is evaluating an opportunity to…